Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 103Breast 19Thoracic 18Genitourinary 18Gynecologic 14Head & Neck 11CNS 5Other hematologic neoplasm 4Other 4Lymphoid 4Classical hematology 4Sarcoma 3Dermatologic 3Other solid neoplasm 1Other neoplasm 1Endocrine 1

Conditions

Neuroendocrine Tumors 532Pituitary Neoplasms 188Multiple Endocrine Neoplasia Type 1 187Thyroid Cancer, Papillary 178Pheochromocytoma 153Carcinoma, Neuroendocrine 140Thyroid Neoplasms 130Neoplasms 107Paraganglioma 99Carcinoid Tumor 99Adrenocortical Carcinoma 92Thyroid Carcinoma, Anaplastic 82Pancreatic Neoplasms 69Neoplasm Metastasis 67Insulinoma 61Adrenal Gland Neoplasms 61Carcinoma, Medullary 59Gastro-enteropancreatic neuroendocrine tumor 58Adenocarcinoma, Follicular 58Carcinoma, Non-Small-Cell Lung 57Breast Neoplasms 56Adenoma, Islet Cell 56Lung Neoplasms 50Sarcoma 49Colorectal Neoplasms 49Carcinoma, Renal Cell 49Melanoma 47Small Cell Lung Carcinoma 45Prostatic Neoplasms 44Head and Neck Neoplasms 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Postoperative Complications × Endocrine × Clear all
NCT06221020 2024-01-24

To Assess the Impact of theERAS Consensus on Patients With Endoscopic Pituitary Tumor Surgery

Chang Gung Memorial Hospital

Unknown
70 enrolled
Endocrine

Pituitary Neoplasms, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡